$PMBS Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$PMBS Up to date company activities and other important information about $PMBS

$PMBS

DD Notes ~ http://www.ddnotesmaker.com/PMBS

##### recent news/filings ~ source: finance.yahoo.com

Fri, 29 Nov 2013 14:00:00 GMT ~ LipiGesic M stands alone among over-the-counter migraine medications based on recently released American Headache Society recommendations
- SCHOFIELD, Wis., Nov. 29, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that its product, LipiGesic® M does not contain caffeine, acetaminophen, or aspirin. It is the only clinically tested, non-prescription migraine medication available on retail shelves today that has shown no evidence of rebound or "medication overuse headache" as a reported side effect. In the article entitled, "Choosing Wisely in Headache Medicine: The American Headache Society's List of Five Things Physicians and Patients Should Question," the authors warn physicians not to "recommend prolonged or frequent use of over-the-counter (OTC) pain medications for headache." The American Headache Society (AHS) article recommended that OTC headache pain relievers should not be used more than twice a week to avoid the incidence of "medication overuse headache," especially when the medications contain caffeine.
read full: http://finance.yahoo.com/news/lipigesic-m-sta...00987.html
*********************************************************

Wed, 27 Nov 2013 18:04:15 GMT ~ PURAMED BIOSCIENCE INC. Financials
read full: http://finance.yahoo.com/q/is?s=pmbs
*********************************************************

Tue, 19 Nov 2013 19:01:39 GMT ~ PURAMED BIOSCIENCE INC. Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/131119/pmbs10-q.html
*********************************************************

Tue, 15 Oct 2013 21:15:33 GMT ~ PURAMED BIOSCIENCE INC. Files SEC form 10-K, Annual Report
read full: http://biz.yahoo.com/e/131015/pmbs10-k.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=PMBS&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=PMBS&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PMBS/company-info
Ticker: $PMBS
OTC Market Place: OTCQB
CIK code: 0001409565
Company name: PuraMed BioScience, Inc.
Incorporated In: MN, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/PMBS/filings
Latest financials: http://www.otcmarkets.com/stock/PMBS/financials
Latest news: http://www.otcmarkets.com/stock/PMBS/news - http://finance.yahoo.com/q/h?s=PMBS+Headlines

Major holdings: http://data.cnbc.com/quotes/PMBS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=PMBS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/PMBS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=PMBS

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=PuraMed+BioScience...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nce%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

http://www.pennystocktweets.com/stocks/profile/PMBS

##### last known share structure ~ source: otcmarkets.com

Market Value: $272,757 a/o Jan 08, 2014
Shares Outstanding: 129,884,289 a/o Dec 31, 2013
Float: Not Available
Authorized Shares: 1,000,000,000 a/o Sep 30, 2013
Par Value: 0.001

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/PMBS

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 6

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Garmin and Noonan Unite to Enhance Golf Experience with Data

Updated Category News Views 317

Garmin and Noonan's Exciting Partnership Garmin, a frontrunner in innovative GPS-enabled sports technology, has partnered with Noonan, a specialist in golf strategy apps. This collaboration marks a significant step forward in enhancing the golfing experience. With technology evolving rapidly, integrating launch monitor data into practical applications revolutionizes how...

Continue Reading
SNDL's New Journey: Trading Now on Canadian Securities Exchange

Updated Category News Views 169

SNDL Begins Trading on the Canadian Securities Exchange SNDL Inc. (Nasdaq: SNDL) has officially announced a new chapter by starting its trading on the Canadian Securities Exchange (CSE) under the same ticker symbol, SNDL. This strategic move has opened doors for the company to tap into the vibrant Canadian market, thus enhancing its operational flexibility. By accessing...

Continue Reading
Investigation of Augmedix, Inc. Merger Vote: Key Insights

Updated Category News Views 60

Understanding Augmedix, Inc.’s Merger and Its Impact on Shareholders Augmedix, Inc. is currently undergoing a major transition that could significantly impact its shareholders. A leading M&A Class Action Firm is conducting investigations to assess the implications of the proposed merger with Commure, Inc. As part of this merger, shareholders are expected to receive...

Continue Reading
Pliant Therapeutics Under Investigation for Possible Securities Fraud

Updated Category News Views 176

Understanding the Investigation of Pliant Therapeutics Pliant Therapeutics, Inc. is currently under investigation concerning potential claims of securities fraud. This investigation has been initiated by legal representatives seeking to protect the interests of investors in the company, particularly in light of their recent business practices that may have raised some red...

Continue Reading
Aspiriant Expands Partner Group with Six New Appointments

Updated Category News Views 212

Aspiriant Expands Partner Group with Six New Appointments Aspiriant, a prominent independent wealth management firm, has announced the exciting addition of six new partners to its ownership group. This move reflects Aspiriant's unwavering commitment to its 100% independent and employee-owned business model, aligning the interests of its employees and clients. With...

Continue Reading